Inositec
Latest round
- Seed
Last raised
- Oct 2016
Total raised
- $1.4M
Investors
- 2
About Inositec
Inositec AG, founded in 2015 and headquartered in Zurich, Switzerland, specializes in therapeutic solutions for nephrology. The company has been involved in two significant deals, with the most recent one occurring on November 22, 2021, when Vifor Pharma Management Ltd. agreed to acquire Inositec AG, although financial terms were not disclosed.Inositec AG is positioned to launch innovative solutions tailored to address specific market needs, focusing on therapeutic advancements in nephrology. Their offerings aim to target diverse customer segments, including individual consumers and businesses. The intended use cases encompass technology integration and efficiency optimization within healthcare, particularly for patients suffering from chronic kidney disease.Inositec AG's revenue model is based on multi-faceted transactional structures, including direct-to-consumer sales and B2B partnerships. The company anticipates revenue generation through various pricing plans designed for both individual consumers and corporate clients. Their flagship products are crafted to provide substantial value, facilitating streamlined purchasing processes that enhance their competitive positioning in the market.Inositec AG plans to leverage the recent acquisition to enhance its nephrology portfolio, particularly in addressing accelerated vascular calcification disorders associated with chronic kidney disease. The acquisition will enable the combined company to focus on further developing innovative therapies aimed at improving patient outcomes. The company's future growth strategies include launching new product lines with specific therapeutic applications, although detailed release dates are not yet disclosed. Furthermore, Inositec AG aims to expand into key geographical markets, specifically targeting North America and Western Europe, where there is a significant demand for advanced therapeutic solutions.
Who invested in Inositec
2 investors across 1 round
See all investors in Inositec
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 27, 2016
Amount
$1.4M
Investors
Questions about Inositec
Who invested in Inositec?
Inositec has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Inositec raised?
Inositec has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Inositec last raise money?
Inositec's most recent round on record is a Seed, in Oct 2016.
What does Inositec do?
Inositec AG, founded in 2015 and headquartered in Zurich, Switzerland, specializes in therapeutic solutions for nephrology.
Where is Inositec headquartered?
Inositec is headquartered in Zurich, Switzerland.
Which VCs invest in companies like Inositec?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back pharmaceuticals companies at Inositec's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like Inositec? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.